Requests that the FDA take specific and necessary actions to address the significant and escalating public health risks associated with the large-scale production and distribution of compounded drug preparations purporting to contain semaglutide | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-P-3239

Requests that the FDA take specific and necessary actions to address the significant and escalating public health risks associated with the large-scale production and distribution of compounded drug preparations purporting to contain semaglutide

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensAug 20, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Withdrawal Request Letter from Wiley Rein LLP	Feb 12, 2026	--

Comment Statistics

Total Comments

Keywords

CDER

Citizen Petition

Wiley Rein LLP

Requests that the FDA take specific and

necessary actions to address the significant and

escalating public health risks associated with

the large-scale production and distribution of

compounded drug preparations

Data from Regulations.gov